Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ann Fowler is active.

Publication


Featured researches published by Ann Fowler.


Journal of Biomolecular Screening | 2006

A Nonradioactive High-Throughput/High-Content Assay for Measurement of the Human Serotonin Reuptake Transporter Function In Vitro

Ann Fowler; Nicole Seifert; Vincent Acker; Tina Woehrle; Claus Kilpert; Antoine De Saizieu

Both the tricyclic and specific serotonin reuptake inhibitor classes of antidepressants act primarily by inhibiting the reuptake of released serotonin by the human serotonin reuptake transporter (hSERT). In this article, the authors describe the use of a fluorescent substrate of the transporter (4-(4-(dimethylamino)-styrl)-N-methylpyridinium, ASP) to develop a microplate-based high-throughput screen for hSERT function. The assay is sensitive to known inhibitors of serotonin uptake, including fluoxetine (Prozac), with the correct rank order of potency and IC50 values close to those reported in the literature for tritiated serotonin uptake. The authors also describe the validation of the assay for natural product screening using a test set of 2400 pure phyto-chemicals and 80 plant extracts. The mean Ź of the screened plates was 0.53. Hit rates, confirmation rates, and validation of the hits in a “classical” assay for serotonin uptake are all reported. The assay can also be read in “high-content” mode using a subcellular imaging device, which allows direct detection of possible assay interference by acutely cytotoxic compounds. Among the compounds identified were several previously reported inhibitors of the hSERT, as well as compounds having structural similarity to the tricyclic antidepressant drugs.


British Journal of Nutrition | 2011

Monoamine reuptake inhibition and mood-enhancing potential of a specified oregano extract

Annis O. Mechan; Ann Fowler; Nicole Seifert; Henry Rieger; Tina Wöhrle; Stephane Etheve; Adrian Wyss; Göde Schüler; Biagio Colletto; Claus Kilpert; James Aston; J. Martin Elliott; Regina Goralczyk; M. Hasan Mohajeri

A healthy, balanced diet is essential for both physical and mental well-being. Such a diet must include an adequate intake of micronutrients, essential fatty acids, amino acids and antioxidants. The monoamine neurotransmitters, serotonin, dopamine and noradrenaline, are derived from dietary amino acids and are involved in the modulation of mood, anxiety, cognition, sleep regulation and appetite. The capacity of nutritional interventions to elevate brain monoamine concentrations and, as a consequence, with the potential for mood enhancement, has not been extensively evaluated. The present study investigated an extract from oregano leaves, with a specified range of active constituents, identified via an unbiased, high-throughput screening programme. The oregano extract was demonstrated to inhibit the reuptake and degradation of the monoamine neurotransmitters in a dose-dependent manner, and microdialysis experiments in rats revealed an elevation of extracellular serotonin levels in the brain. Furthermore, following administration of oregano extract, behavioural responses were observed in mice that parallel the beneficial effects exhibited by monoamine-enhancing compounds when used in human subjects. In conclusion, these data show that an extract prepared from leaves of oregano, a major constituent of the Mediterranean diet, is brain-active, with moderate triple reuptake inhibitory activity, and exhibits positive behavioural effects in animal models. We postulate that such an extract may be effective in enhancing mental well-being in humans.


Molecules | 2016

Carnosol and Related Substances Modulate Chemokine and Cytokine Production in Macrophages and Chondrocytes

Joseph Schwager; Nathalie Richard; Ann Fowler; Nicole Seifert; Daniel Raederstorff

Phenolic diterpenes present in Rosmarinus officinalis and Salvia officinalis have anti-inflammatory and chemoprotective effects. We investigated the in vitro effects of carnosol (CL), carnosic acid (CA), carnosic acid-12-methylether (CAME), 20-deoxocarnosol and abieta-8,11,13-triene-11,12,20-triol (ABTT) in murine macrophages (RAW264.7 cells) and human chondrocytes. The substances concentration-dependently reduced nitric oxide (NO) and prostaglandin E2 (PGE2) production in LPS-stimulated macrophages (i.e., acute inflammation). They significantly blunted gene expression levels of iNOS, cytokines/interleukins (IL-1α, IL-6) and chemokines including CCL5/RANTES, CXCL10/IP-10. The substances modulated the expression of catabolic and anabolic genes in chondrosarcoma cell line SW1353 and in primary human chondrocytes that were stimulated by IL-1β (i.e., chronic inflammation In SW1353, catabolic genes like MMP-13 and ADAMTS-4 that contribute to cartilage erosion were down-regulated, while expression of anabolic genes including Col2A1 and aggrecan were shifted towards pre-pathophysiological homeostasis. CL had the strongest overall effect on inflammatory mediators, as well as on macrophage and chondrocyte gene expression. Conversely, CAME mainly affected catabolic gene expression, whereas ABTT had a more selectively altered interleukin and chemokine gene exprssion. CL inhibited the IL-1β induced nuclear translocation of NF-κBp65, suggesting that it primarily regulated via the NF-κB signalling pathway. Collectively, CL had the strongest effects on inflammatory mediators and chondrocyte gene expression. The data show that the phenolic diterpenes altered activity pattern of genes that regulate acute and chronic inflammatory processes. Since the substances affected catabolic and anabolic gene expression in cartilage cells in vitro, they may beneficially act on the aetiology of osteoarthritis.


Current Opinion in Biotechnology | 2008

Challenges in discovering bioactives for the food industry.

Joseph Schwager; M. Hasan Mohajeri; Ann Fowler; Peter Weber


Archive | 2008

Novel nutraceutical compositions containing stevia extract or stevia extract constituents and uses thereof

Ann Fowler; Regina Goralczyk; Claus Kilpert; Annis Olivia Mayne-Mechan; Bernd Mussler; Adrian Wyss


Archive | 2007

NOVEL AGENTS FOR THE TREATMENT OF DISORDERS CONNECTED TO IMPAIRED NEUROTRANSMISSION

Ann Fowler; Regina Goralczyk; Claus Kilpert; Goede Schueler


Archive | 2009

Hydroxytyrosol combinations for enhancing mitochondrial function and energy production

Ann Fowler; Angelika Friedel; Darko Knutti; Karin Kuratli; Daniel Raederstorff; Ying Wang-Schmidt; Karin Wertz


Archive | 2007

Dietary or pharmaceutical compositions containing tricyclic diterpenes and derivatives thereof for the treatment of depression

Saizieu Antoine De; Ann Fowler; Regina Goralczyk; Claus Kilpert; Goede Schueler; Christof Wehrli


Archive | 2007

ROSEMARY EXTRACTS, DIETARY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES

Antoine De Saizieu; Ann Fowler; Regina Goralczyk; Claus Kilpert; Goede Schueler


Archive | 2006

Ligustilide derivatives for the treatment of inflammatory disorders.

Ann Fowler; Daniel Raederstorff; Goede Schuler; Joseph Schwager

Researchain Logo
Decentralizing Knowledge